SBX — SynBiotic SE Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- €42.94m
- €45.01m
- €8.17m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.9 | ||
| Price to Tang. Book | 2.08 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.26 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -74.31% | ||
| Return on Equity | -125.22% | ||
| Operating Margin | -317.47% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | n/a | 5.45 | 8.65 | 8.17 | 5.47 | 10.94 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SynBiotic SE is a Germany-based investment company. Mainly the Company invests in cannabinoid focused ventures and teams.
Directors
- Sebastian Stietzel CSU
- Lars Mueller CEO
- Le Roy Dowey CEX
- James Linden CEX
- Rainer Seiler OTH
- Marlon Braumann SUB
- Thomas Hanke SUB
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2021
- Incorporated
- April 25th, 2018
- Public Since
- May 13th, 2021
- No. of Employees
- 104
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Dusseldorf Stock Exchange
- Shares in Issue
- 4,677,379
- Address
- Barer Str. 7, MUENCHEN, 80333
- Web
- https://www.synbiotic.com/
- Phone
- Auditors
- MAZARS
Upcoming Events for SBX
SynBiotic SE Annual Shareholders Meeting
Similar to SBX
Cannovum Cannabis AG
Dusseldorf Stock Exchange
Medios AG
Dusseldorf Stock Exchange
Viromed Medical AG
Dusseldorf Stock Exchange
FAQ
What is the SynBiotic SE share price?
As of Today at 19:21 UTC, shares in SynBiotic SE are trading at €9.18. This share price information is delayed by 15 minutes.
How has the SynBiotic SE share price performed this year?
Shares in SynBiotic SE last closed at €9.18 and the price had moved by +67.37% over the past 365 days. In terms of relative price strength the SynBiotic SE share price has outperformed the FTSE Global All Cap Index by +57.13% over the past year.
What are the analyst and broker recommendations for SynBiotic SE?
The overall consensus recommendation for SynBiotic SE is Strong Sell. You can view the full broker recommendation list by unlocking its StockReport.
What is the SynBiotic SE dividend yield?
SynBiotic SE does not currently pay a dividend.
Does SynBiotic SE pay a dividend?
SynBiotic SE does not currently pay a dividend.
When does SynBiotic SE next pay dividends?
SynBiotic SE does not currently pay a dividend.
How do I buy SynBiotic SE shares?
To buy shares in SynBiotic SE you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of SynBiotic SE?
As of the previous close price of €9.18, shares in SynBiotic SE had a market capitalisation of €42.94m.
Where are SynBiotic SE shares listed?
Here are the trading details for SynBiotic SE:
- Country of listing: Germany
- Exchange: DUS
- Ticker Symbol: SBX
What kind of share is SynBiotic SE?
Based on an overall assessment of its quality, value and momentum SynBiotic SE is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a SynBiotic SE share price forecast for 2024?
The analyst consensus target price for shares in SynBiotic SE is €15.00. That is 63.4% above the last closing price of €9.18.
Analysts covering SynBiotic SE currently have a consensus Earnings Per Share (EPS) forecast of -€0.58 for the next financial year.
What is the trend in the SynBiotic SE share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SynBiotic SE. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +165.29%.
As of the last closing price of €9.18, shares in SynBiotic SE were trading +67.42% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the SynBiotic SE PE Ratio?
The SynBiotic SE PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €9.18.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of SynBiotic SE?
SynBiotic SE's management team is headed by:
- Sebastian Stietzel - CSU
- Lars Mueller - CEO
- Le Roy Dowey - CEX
- James Linden - CEX
- Rainer Seiler - OTH
- Marlon Braumann - SUB
- Thomas Hanke - SUB